Shou Xian Valley (603896.SH): No cooperation with Zhejiang Hospital of Traditional Chinese Medicine on Wu Mei Soup

Gelonghui, May 27丨Shouxiangu (603896.SH) said on the investor interactive platform that the company has yet to cooperate with Zhejiang Hospital of Traditional Chinese Medicine on Wumei Soup.

Gelonghui FinanceMay 27 03:41 ET

Shouxianggu (603896.SH): Did not participate in this Shenzhou 17 space flight test

Gelonghui, May 7, 丨 Shouxiangu (603896.SH) said on the investor interactive platform that the company carried out six space breeding work in 2003, 2005, 2012, 2013, 2016 and 2021, respectively, and did not participate in this Shenzhou 17 space launch test.

Gelonghui FinanceMay 7 05:45 ET

Shouxianggu (603896.SH): Net profit of 77.132 million yuan in the first quarter increased 23.19% year-on-year

On April 25, Ge Longhui (603896.SH) released its report for the first quarter of 2024, achieving operating income of 221 million yuan, up 7.15% year on year; net profit attributable to shareholders of listed companies of 77.132 million yuan, up 23.19% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 68.1435 million yuan, an increase of 22.30% year on year; basic earnings per share of 0.39 yuan.

Gelonghui FinanceApr 25 09:19 ET

While Shareholders of Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Are in the Red Over the Last Year, Underlying Earnings Have Actually Grown

The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realiz

Simply Wall StApr 23 19:03 ET

Could The Market Be Wrong About Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) Given Its Attractive Financial Prospects?

It is hard to get excited after looking at Zhejiang Shouxiangu Pharmaceutical's (SHSE:603896) recent performance, when its stock has declined 18% over the past three months. However, stock prices ar

Simply Wall StMar 22 20:14 ET

Shousengoku (603896.SH): Third-generation deswalled Ganoderma lucidum spore powder product has health benefits to enhance immunity

Gelonghui, March 13 | Shouxianggu (603896.SH) said on the investor interactive platform that the key to preventing viral infections is to improve autoimmunity. The company's third-generation Ganoderma lucidum spore powder products have health benefits to enhance immunity.

Gelonghui FinanceMar 13 03:39 ET